Gene expression changes induced by a recombinant E1-/E3 - adenovirus type 5 vector in human mammary epithelial cells

Intervirology

Volumn 48, Issue 6, 2005, Pages 350-361

  Scibetta, Angelo G ^a   Copier, John ^b   Barrett, Angela ^a   Chaplin, Tracy ^c   Taylor Papadimitriou, Joyce ^a  

^a GUY S HOSPITAL   (United Kingdom)

^b IMPERIAL CANCER RESEARCH FUND   (United Kingdom)

^c QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

Adenoviruses; Gene expression; Mammary epithelial cells; Microarray

Indexed keywords

ADENOVIRUS VECTOR; VIRUS RNA;

ADENOVIRUS 5; ARTICLE; BREAST EPITHELIUM; CELL LINE; CELL PROLIFERATION; CONTROLLED STUDY; DNA MICROARRAY; GENE EXPRESSION; GENE EXPRESSION REGULATION; GENETIC TRANSDUCTION; HUMAN; HUMAN CELL; IMMUNE RESPONSE; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; VIRUS RECOMBINANT;

ADENOVIRUS E1 PROTEINS; ADENOVIRUS E3 PROTEINS; ADENOVIRUSES, HUMAN; CELL LINE; DEFECTIVE VIRUSES; EPITHELIAL CELLS; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENETIC VECTORS; HUMANS; MAMMARY GLANDS, HUMAN; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

ADENOVIRIDAE; HUMAN ADENOVIRUS TYPE 5;

EID: 22344456494     PISSN: 03005526     EISSN: None     Source Type: Journal    
DOI: 10.1159/000086062     Document Type: Article

References (69)

1. Russell WC: Update on adenoviras and its vectors. J Gen Virol 2000;81:2573-2604.
2. Morsy MA, Gu M, Motzel S, Zhao J, Lin J, Su Q, Allen H, Franlin L, Parks RJ, Graham FL, Kochanek S, Bett AJ, Caskey CT: An adenoviral vector deleted for all viral coding sequences results in enhanced safety and extended expression of a leptin transgene. Proc Natl Acad Sci USA 1998;95:7866-7871.
3. Shenk T: Adenoviridae: The viruses and their replication; in Fields BN, Knipe DM, Howley PM, Chanock RM, Monath TP, Melnick JL, Roizman B, Strauss SE (ed): Fields Virology. Lippincott, Philadelphia, 1996.
4. Merrick AF, Shewring LD, Sawyer GJ, Gustafsson KT, Fahre JW: Comparison of adenovirus gene transfer to vascular endothelial cells in cell culture, organ culture, and in vivo. Transplantation 1996;62:1085-1089.
5. Roessler BJ, Allen ED, Wilson JM, Hartman JW, Davidson BL: Adenoviral-mediated gene transfer to rabbit synovium in vivo. J Clin Invest 1993;92:1085-1092.
6. Howell JM, Lochmuller H, O'Hara A, Fletcher S, Kakulas BA, Massie B, Nalbantoglu J, Karpati G: High-level dystrophin expression after adenovirus-mediated dystrophin minigene transfer to skeletal muscle of dystrophic dogs: Prolongation of expression with immunosuppression. Hum Gene Ther 1998;9:629-634.
7. Ramalingam R, Rafii S, Worgall S, Hackett NR, Crystal RG: Induction of endogenous genes following infection of human endothelial cells with an E1(-) E4(+) adenovirus gene transfer vector. J Virol 1999;73:10183-10190.
8. Clesham GJ, Adam PJ, Proudfoot D, Flynn PD, Efstathiou S, Weissberg PL: High adenoviral loads stimulate NF κB-dependent gene expression in human vascular smooth muscle cells. Gene Ther 1998;5:174-180.
9. Lieber A, He CY, Meuse L, Schowalter D, Kirillova I, Winther B, Kay MA: The role of Kupffer cell activation and viral gene expression in early liver toxicity after infusion of recombinant adenovirus vectors. J Virol 1997;71:8798-8807.
10. McElvaney NG, Crystal RG: IL-6 release and airway administration of human CFR cDNA adenovirus vector. Nat Med 1995;1:182-184.
11. Newman KD, Dunn PF, Owens JW, Schulick AH, Virmani R, Sukhova G, Libby P, Dichek DA: Adenovirus-mediated gene transfer into normal rabbit arteries results in prolonged vascular cell activation, inflammation, and neointimal hyperplasia. J Clin Invest 1995;96:2955-2965.
12. Zhao H, Granberg F, Elfineh L, Pettersson U, Svensson C: Strategic attack on host cell gene expression during adenovirus infection. J Virol 2003;77:11006-11015.
13. Stilwell JL, McCarty DM, Negishi A, Superfine R, Samulski RJ: Development and characterization of novel empty adenovirus capsids and their impact on cellular gene expression. J Virol 2003;77:12881-12885.
14. Horwitz MS: Adenoviruses. Philadelphia, Lippincott, 1996.
15. Graham FL, Smiley J, Russell WC, Nairn R: Characteristics of a human cell line transformed by DNA from human adenovirus type 5. J Gen Virol 1977;36:59-74.
16. Moorhead JW, Clayton GH, Smith RL, Schaack J: A replication-incompetent adenovirus vector with the preterminal protein gene deleted efficiently transduces mouse ears. J Virol 1999;73:1046-1053.
17. Lusky M, Christ M, Rittner K, Dieterle A, Dreyer D, Mourot B, Schultz H, Stoeckel F, Pavirani A, Mehtali M: In vitro and in vivo biology of recombinant adenovirus vectors with E1, E1/E2A, or E1/E4 deleted. J Virol 1998;72:2022-2032.
18. Amalfitano A, McVie-Wylie AJ, Hu H, Dawson TL, Raben N, Plotz P, Chen YT: Systemic correction of the muscle disorder glycogen storage disease type II after hepatic targeting of a modified adenovirus vector encoding human acid-α-glucosidase. Proc Natl Acad Sci USA 1999;96:8861-8866.
19. Steinwaerder DS, Carlson CA, Lieber A: Generation of adenovirus vectors devoid of all viral genes by recombination between inverted repeats. J Virol 1999;73:9303-9313.
20. Menssen A, Hermeking H: Characterization of the c-MYC-regulated transcriptome by SAGE: Identification and analysis of c-MYC target genes. Proc Natl Acad Sci USA 2002;99:6274-6279.
21. Ma Y, Croxton R, Moorer RL Jr, Cress WD: Identification of novel E2F1-regulated genes by microarray. Arch Biochem Biophys 2002;399:212-224.
22. Tibbles LA, Spurrell JC, Bowen GP, Liu Q, Lam M, Zaiss AK, Robbins SM, Hollenberg MD, Wickham TJ, Muruve DA: Activation of p38 and ERK signaling during adenovirus vector cell entry lead to expression of the C-X-C chemokine IP-10. J Virol 2002;76:1559-1568.
23. Liu Q, Zaiss AK, Colarusso P, Patel K, Haljan G, Wickham TJ, Muruve DA: The role of capsid-endothelial interactions in the innate immune response to adenovirus vectors. Hum Gene Ther 2003;14:627-643.
24. Russell TD, Fischer A, Beeman NE, Freed EF, Neville MC, Schaack J: Transduction of the mammary epithelium with adenovirus vectors in vivo. J Virol 2003;77:5801-5809.
25. Wickham TJ, Mathias P, Cheresh DA, Nemerow GR: Integrins alpha v beta 3 and alpha v beta 5 promote adenovirus internalization but not virus attachment. Cell 1993;73:309-319.
26. Greber UF, Willetts M, Webster P, Helenius A: Stepwise dismantling of adenovirus 2 during entry into cells. Cell 1993;75:477-486.
27. Berdichevsky F, Gilbert C, Shearer M, Taylor-Papadimitriou J: Collagen-induced rapid morphogenesis of human mammary epithelial cells: The role of the alpha 2 beta 1 integrin. J Cell Sci 1992;102(pt 3):437-446.
28. Bartek J, Bartkova J, Kyprianou N, Lalani EN, Staskova Z, Shearer M, Chang S, Taylor-Papadimitriou J: Efficient immortalization of luminal epithelial cells from human mammary gland by introduction of simian virus 40 large tumor antigen with a recombinant retrovirus. Proc Natl Acad Sci USA 1991;88:3520-3524.
29. He TC, Zhou S, da Costa LT, Yu J, Kinzler KW, Vogelstein B: A simplified system for generating recombinant adenoviruses. Proc Natl Acad Sci USA 1998;95:2509-2514.
30. Adachi M, Taki T, Higashiyama M, Kohno N, Inufusa H, Miyake M: Significance of integrin α5 gene expression as a prognostic factor in node-negative non-small cell lung cancer. Clin Cancer Res 2000;6:96-101.
31. Rodriguez E, Lopez R, Paez A, Masso F, Montano LF: 17β-estradiol inhibits the adhesion of leukocytes in TNF-α stimulated human endothelial cells by blocking IL-8 and MCP-1 secretion, but not its transcription. Life Sci 2002;71:2181-2193.
32. Martens JH, Verlaan M, Kalkhoven E, Zantema A: Cascade of distinct histone modifications during collagenase gene activation. Mol Cell Biol 2003;23:1808-1816.
33. Bruder JT, Kovesdi I: Adenovirus infection stimulates the Raf/MAPK signaling pathway and induces interleukin-8 expression. J Virol 1997;71:398-404.
34. Natarajan K, Rajala MS, Chodosh J: Corneal IL-8 expression following adenovirus infection is mediated by c-Src activation in human corneal fibroblasts. J Immunol 2003;170:6234-6243.
35. Crystal RG, McElvaney NG, Rosenfeld MA, Chu CS, Mastrangeli A, Hay JG, Brody SL, Jaffe HA, Eissa NT, Danel C: Administration of an adenovirus containing the human CFTR cDNA to the respiratory tract of individuals with cystic fibrosis. Nat Genet 1994;8:42-51.
36. Murphy EV, Zhang Y, Zhu W, Biggs J: The human glioma pathogenesis-related protein is structurally related to plant pathogenesis-related proteins and its gene is expressed specifically in brain tumors. Gene 1995;159:131-135.
37. Stintzi A, Heitz T, Prasad V, Wiedemann-Merdinoglu S, Kauffmann S, Geoffroy P, Legrand M, Fritig B: Plant 'pathogenesis-related' proteins and their role in defense against pathogens. Biochimie 1993;75:687-706.
38. Niderman T, Genetet I, Bruyere T, Gees R, Stintzi A, Legrand M, Fritig B, Mosinger E: Pathogenesis-related PR-1 proteins are antifungal. Isolation and characterization of three 14-kilodalton proteins of tomato and of a basic PR-I of tobacco with inhibitory activity against Phytophthora infestans. Plant Physiol 1995;108:17-27.
39. Beffa R, Szell M, Meuwly P, Pay A, Vogeli-Lange R, Metraux JP, Neuhaus G, Meins F Jr, Nagy F: Cholera toxin elevates pathogen resistance and induces pathogenesis-related gene expression in tobacco. Embo J 1995;14:5753-5761.
40. Scheuring UJ, Corbeil J, Mosier DE, Theofilopoulos AN: Early modification of host cell gene expression induced by HIV-1. Aids 1998;12:563-570.
41. Holmes DI, Wahab NA, Mason RM: Cloning and characterization of ZNF236, a glucose-regulated Kruppel-like zinc-finger gene mapping to human chromosome 18q22-q23. Genomics 1999;60:105-109.
42. Kaplan JM, Armentano D, Scaria A, Wood-worth LA, Pennington SE, Wadsworth SC, Smith AE, Gregory RJ: Novel role for E4 region genes in protection of adenovirus vectors from lysis by cytotoxic T lymphocytes. J Virol 1999;73:4489-4492.
43. Ginsberg HS, Lundholm-Beauchamp U, Horswood RL, Pernis B, Wold WS, Chanock RM, Prince GA: Role of early region 3 (E3) in pathogenesis of adenovirus disease. Proc Natl Acad Sci USA 1989;86:3823-3827.
44. Ginsberg HS, Moldawer LL, Sehgal PB, Redington M, Kilian PL, Chanock RM, Prince GA: A mouse model for investigating the molecular pathogenesis of adenovirus pneumonia. Proc Natl Acad Sci USA 1991;88:1651-1655.
45. Wilmott RW, Amin RS, Perez CR, Wert SE, Keller G, Boivin GP, Hirsch R, De Inocencio J, Lu P, Reising SF, Yei S, Whitsett JA, Trapnell BC: Safety of adenovirus-mediated transfer of the human cystic fibrosis transmembrane conductance regulator cDNA to the lungs of nonhuman primates. Hum Gene Ther 1996;7:301-318.
46. Amin R, Wilmott R, Schwarz Y, Trapnell B, Stark J: Replication-deficient adenovirus induces expression of interleukin-8 by airway epithelial cells in vitro. Hum Gene Ther 1995;6:145-153.
47. Chen D, Murphy B, Sung R, Bromberg JS: Adaptive and innate immune responses to gene transfer vectors: Role of cytokines and chemokines in vector function. Gene Ther 2003;10:991-998.
48. Bennett J: Immune response following intraocular delivery of recombinant viral vectors. Gene Ther 2003;10:977-982.
49. Muruve DA, Barnes MJ, Stillman IE, Libermann TA: Adenoviral gene therapy leads to rapid induction of multiple chemokines and acute neutrophil-dependent hepatic injury in vivo. Hum Gene Ther 1999;10:965-976.
50. Jooss K, Chirmule N: Immunity to adenoviras and adeno-associated viral vectors: Implications for gene therapy. Gene Ther 2003;10:955-963.
51. Bergelson JM, Cunningham JA, Droguett G, Kurt-Jones EA, Krithivas A, Hong JS, Horwitz MS, Crowell RL, Finberg RW: Isolation of a common receptor for Coxsackie B viruses and adenoviruses 2 and 5. Science 1997;275:1320-1323.
52. Roelvink PW, Lizonova A, Lee JG, Li Y, Bergelson JM, Finberg RW, Brough DE, Kovesdi I, Wickham TJ: The coxsackievirus-adenovirus receptor protein can function as a cellular attachment protein for adenovirus serotypes from subgroups A, C, D, E, and F. J Virol 1998;72:7909-7915.
53. Li E, Brown SL, Stupack DG, Puente XS, Cheresh DA, Nemerow GR: Integrin α(v)β1 is an adenovirus coreceptor. J Virol 2001;75:5405-5409.
54. Rauma T, Tuukkanen J, Bergelson JM, Denning G, Hautala T: rab5 GTPase regulates adenovirus endocytosis. J Virol 1999;73:9664-9668.
55. Cary LA, Han DC, Guan JL: Integrin-mediated signal transduction pathways. Histol Histopathol 1999;14:1001-1009.
56. Schaller MD, Hildebrand JD, Parsons JT: Complex formation with focal adhesion kinase: A mechanism to regulate activity and subcellular localization of Src kinases. Mol Biol Cell 1999;10:3489-3505.
57. Roebuck KA: Oxidant stress regulation of IL-8 and ICAM-1 gene expression: Differential activation and binding of the transcription factors AP-1 and NF-κB (review). Int J Mol Med 1999;4:223-230.
58. Julkunen I, Sareneva T, Pirhonen J, Ronni T, Melen K, Matikainen S: Molecular pathogenesis of influenza A virus infection and virus-induced regulation of cytokine gene expression. Cytokine Growth Factor Rev 2001;12:171-180.
59. Denk A, Goebeler M, Schmid S, Berberich I, Ritz O, Lindemann D, Ludwig S, Wirth T: Activation of NF-κB via the IκB kinase complex is both essential and sufficient for proinflammatory gene expression in primary endothelial cells. J Biol Chem 2001;276:28451-28458.
60. Kafri T, Morgan D, Krahl T, Sarvetnick N, Sherman L, Verma I: Cellular immune response to adenoviral vector infected cells does not require de novo viral gene expression: Implications for gene therapy. Proc Natl Acad Sci USA 1998;95:11377-11382.
61. 2 and tumor necrosis factor-α induce differential binding of the redox-responsive transcription factors AP-1 and NF-κB to the interleukin-8 promoter in endothelial and epithelial cells. J Biol Chem 1998;273:32670-32678.
62. Ghosh S, May MJ, Kopp EB: NF-kappa B and Rel proteins: Evolutionarily conserved mediators of immune responses. Annu Rev Immunol 1998;16:225-260.
63. May MJ, Ghosh S: Signal transduction through NF-kappa B. Immunol Today 1998;19:80-88.
64. Su F, Schneider RJ: Hepatitis B virus HBx protein activates transcription factor NF-κB by acting on multiple cytoplasmic inhibitors of rel-related proteins. J Virol 1996;70:4558-4566.
65. You LR, Chen CM, Lee YH: Hepatitis C virus core protein enhances NF-κB signal pathway triggering by lymphotoxin-β receptor ligand and tumor necrosis factor α. J Virol 1999;73:1672-1681.
66. Kopp EB, Ghosh S: NF-kappa B and rel proteins in innate immunity. Adv Immunol 1995;58:1-27.
67. Olivetta E, Percario Z, Fiorucci G, Mattia G, Schiavoni I, Dennis C, Jager J, Harris M, Romeo G, Affabris E, Federico M: HIV-1 Nef induces the release of inflammatory factors from human monocyte/macrophages: Involvement of Nef endocytotic signals and NF-kappa B activation. J Immunol 2003;170:1716-1727.
68. Bours V, Burd PR, Brown K, Villalobos J, Park S, Ryseck RP, Bravo R, Kelly K, Siebenlist U: A novel mitogen-inducible gene product related to p50/p105-NF-kappa B participates in transactivation through a kappa B site. Mol Cell Biol 1992;12:685-695.
69. Muruve DA, Nicolson AG, Manfro RC, Strom TB, Sukhatme VP, Libermann TA: Adenovirus-mediated expression of Fas ligand induces hepatic apoptosis after systemic administration and apoptosis of ex vivo-infected 7ancreatic islet allografts and isografts. Hum Gene Ther 1997;8:955-963.